Global generic drugs market was valued at USD371.04 billion in 2020 and is anticipated to reach USD564.43 billion until 2026 by witnessing a CAGR of 7.08% during the forecast period. The global generic drugs market is driven by rising prevalence of chronic diseases across the globe. Moreover, availability of generic drugs at a lower cost and having the same chemical composition of branded drugs is one of the key factors which is positively impacting the growth of market during the forecast period. Also, increasing count of drug patent expirations is further expected to bolster the growth of market over the next few years.

The global generic drugs market is segmented based on type, application, drug delivery, form, source, distribution channel, company, and region. In terms of application, the market can be categorized into cardiovascular diseases, diabetes, neurology, oncology, anti-inflammatory diseases, others. Out of which, the cardiovascular diseases segment dominated the market by holding 35.05% market share in 2020 and the segment is expected to maintain its leading position in the market during the forecast period as well. This can be ascribed to majority of population dealing with cardiovascular diseases across the globe.  On the contrary, diabetes segment is anticipated to register the highest growth in the coming years which can be attributed to ever increasing prevalence of diabetes predominantly in Asia-Pacific region. Also, growing use of metformin generic drug for the treatment of diabetes owing to its effectiveness, is further contributing to the segmental growth. 

The major players operating in the global generic drugs market are Teva Pharmaceutical Industries Ltd, Mylan NV, Sandoz International GmbH (Novartis AG), Lupin Limited, Pfizer Inc., Sun Pharmaceutical Industries Limited, Endo Pharmaceuticals Inc., Aurobindo Pharma Limited, Dr Reddy’s Laboratories Ltd., Fresenius Kabi AG, Aspen Pharmacare Holdings Limited, Sanofi S.A., Cipla Ltd., Novo Nordisk A/S, Abbott Laboratories Inc., and others. Major companies are developing advanced technologies and launching new products to stay competitive in the market. Other competitive strategies include mergers & acquisitions, partnership, agreements, and new developments in order to expand their geographic reach and to increase their customer base.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022–2026

Objective of the Study:

  • To analyze historical growth in market size of global generic drugs market from 2016 to 2019.
  • To estimate and forecast the market size of global generic drugs market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast global generic drugs market based on type, application, drug delivery, form, source, distribution channel, company and regional distribution.
  • To identify dominant region or segment in the global generic drugs market.
  • To identify drivers and challenges for global generic drugs market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global generic drugs market.
  • To conduct pricing analysis for global generic drugs market.
  • To identify and analyze the profiles of leading players operating in global generic drugs market.
  • To identify key sustainable strategies adopted by market players in global generic drugs market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the products and presence of all major players across the globe.

TechSci Research calculated the market size of global generic drugs market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Generic drugs manufacturers
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to generic drugs

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global generic drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Generic Drugs Market, By Type:
    • Small Molecule Generics
    • Biosimilars
  • Global Generic Drugs Market, By Application:
    • Cardiovascular Diseases
    • Diabetes
    • Neurology
    • Oncology
    • Anti-Inflammatory Diseases
    • Others
  • Global Generic Drugs Market, By Drug Delivery:
    • Oral
    • Topical
    • Parenteral
    • Others
  • Global Generic Drugs Market, By Form:
    • Tablet
    • Capsule
    • Injection
    • Others
  • Global Generic Drugs Market, By Source:
    • In House
    • Contract Manufacturing Organizations
  • Global Generic Drugs Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Others
  • Global Generic Drugs Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global generic drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Generic Drugs Market

4.    Executive Summary

5.    Voice of Customer

5.1.  Brand Awareness

5.2.  Factors driving Global Generic Drugs Market

5.3.  Factors Influencing Drug Purchase Decision

6.    Global Generic Drugs Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Type (Small Molecule Generics vs Biosimilars)

6.2.2.     By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others)

6.2.3.     By Drug Delivery (Oral, Topical, Parenteral, Others)

6.2.4.     By Form (Tablet, Capsule, Injection, Others)

6.2.5.     By Source (In House vs Contract Manufacturing Organizations)

6.2.6.     By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others

6.2.7.     By Region

6.2.8.     By Company (2020)

6.3.  Product Market Map

7.    North America Generic Drugs Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Type

7.2.2.     By Application

7.2.3.     By Drug Delivery

7.2.4.     By Form

7.2.5.     By Source

7.2.6.     By Distribution Channel

7.2.7.     By Country (United States; Canada; Mexico)

7.3.  North America: Country Analysis

7.3.1.     United States Generic Drugs Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Type

7.3.1.2.2.             By Application

7.3.1.2.3.             By Drug Delivery

7.3.1.2.4.             By Form

7.3.1.2.5.             By Source

7.3.1.2.6.             By Distribution Channel

7.3.2.     Canada Generic Drugs Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Type

7.3.2.2.2.             By Application

7.3.2.2.3.             By Drug Delivery

7.3.2.2.4.             By Form

7.3.2.2.5.             By Source

7.3.2.2.6.             By Distribution Channel

7.3.3.     Mexico Generic Drugs Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Type

7.3.3.2.2.             By Application

7.3.3.2.3.             By Drug Delivery

7.3.3.2.4.             By Form

7.3.3.2.5.             By Source

7.3.3.2.6.             By Distribution Channel

8.    Europe Generic Drugs Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Type

8.2.2.     By Application

8.2.3.     By Drug Delivery

8.2.4.     By Form

8.2.5.     By Source

8.2.6.     By Distribution Channel

8.2.7.     By Country (France; Germany; UK; Italy; Spain)

8.3.  Europe: Country Analysis

8.3.1.     Germany Generic Drugs Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Type

8.3.1.2.2.             By Application

8.3.1.2.3.             By Drug Delivery

8.3.1.2.4.             By Form

8.3.1.2.5.             By Source

8.3.1.2.6.             By Distribution Channel

8.3.2.     France Generic Drugs Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Type

8.3.2.2.2.             By Application

8.3.2.2.3.             By Drug Delivery

8.3.2.2.4.             By Form

8.3.2.2.5.             By Source

8.3.2.2.6.             By Distribution Channel

8.3.3.     United Kingdom Generic Drugs Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Type

8.3.3.2.2.             By Application

8.3.3.2.3.             By Drug Delivery

8.3.3.2.4.             By Form

8.3.3.2.5.             By Source

8.3.3.2.6.             By Distribution Channel

8.3.4.     Italy Generic Drugs Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Type

8.3.4.2.2.             By Application

8.3.4.2.3.             By Drug Delivery

8.3.4.2.4.             By Form

8.3.4.2.5.             By Source

8.3.4.2.6.             By Distribution Channel

8.3.5.     Spain Generic Drugs Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Type

8.3.5.2.2.             By Application

8.3.5.2.3.             By Drug Delivery

8.3.5.2.4.             By Form

8.3.5.2.5.             By Source

8.3.5.2.6.             By Distribution Channel

9.    Asia-Pacific Generic Drugs Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Type

9.2.2.     By Application

9.2.3.     By Drug Delivery

9.2.4.     By Form

9.2.5.     By Source

9.2.6.     By Distribution Channel

9.2.7.     By Country (China; India; Japan; South Korea; Australia)

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Generic Drugs Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Type

9.3.1.2.2.             By Application

9.3.1.2.3.             By Drug Delivery

9.3.1.2.4.             By Form

9.3.1.2.5.             By Source

9.3.1.2.6.             By Distribution Channel

9.3.2.     India Generic Drugs Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Type

9.3.2.2.2.             By Application

9.3.2.2.3.             By Drug Delivery

9.3.2.2.4.             By Form

9.3.2.2.5.             By Source

9.3.2.2.6.             By Distribution Channel

9.3.3.     Australia Generic Drugs Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Type

9.3.3.2.2.             By Application

9.3.3.2.3.             By Drug Delivery

9.3.3.2.4.             By Form

9.3.3.2.5.             By Source

9.3.3.2.6.             By Distribution Channel

9.3.4.     South Korea Generic Drugs Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Type           

9.3.4.2.2.             By Application

9.3.4.2.3.             By Drug Delivery

9.3.4.2.4.             By Form

9.3.4.2.5.             By Source

9.3.4.2.6.             By Distribution Channel

9.3.5.     Japan Generic Drugs Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Type

9.3.5.2.2.             By Application

9.3.5.2.3.             By Drug Delivery

9.3.5.2.4.             By Form

9.3.5.2.5.             By Source

9.3.5.2.6.             By Distribution Channel

10.  Middle East and Africa Generic Drugs Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Type

10.2.2.  By Application

10.2.3.  By Drug Delivery

10.2.4.  By Form

10.2.5.  By Source

10.2.6.  By Distribution Channel

10.2.7.  By Country (UAE; Saudi Arabia; South Africa)

10.3.              MEA: Country Analysis

10.3.1.  South Africa Generic Drugs Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Type

10.3.1.2.2.           By Application

10.3.1.2.3.           By Drug Delivery

10.3.1.2.4.           By Form

10.3.1.2.5.           By Source

10.3.1.2.6.           By Distribution Channel

10.3.2.  Saudi Arabia Generic Drugs Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Type

10.3.2.2.2.           By Application

10.3.2.2.3.           By Drug Delivery

10.3.2.2.4.           By Form

10.3.2.2.5.           By Source

10.3.2.2.6.           By Distribution Channel

10.3.3.  UAE Generic Drugs Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Type

10.3.3.2.2.           By Application

10.3.3.2.3.           By Drug Delivery

10.3.3.2.4.           By Form

10.3.3.2.5.           By Source

10.3.3.2.6.           By Distribution Channel

11.  South America Generic Drugs Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Type

11.2.2.  By Application

11.2.3.  By Drug Delivery

11.2.4.  By Form

11.2.5.  By Source

11.2.6.  By Distribution Channel

11.2.7.  By Country (Brazil; Argentina; Colombia)

11.3.              South America: Country Analysis

11.3.1.  Brazil Generic Drugs Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Type

11.3.1.2.2.           By Application

11.3.1.2.3.           By Drug Delivery

11.3.1.2.4.           By Form

11.3.1.2.5.           By Source

11.3.1.2.6.           By Distribution Channel

11.3.2.  Argentina Generic Drugs Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Type

11.3.2.2.2.           By Application

11.3.2.2.3.           By Drug Delivery

11.3.2.2.4.           By Form

11.3.2.2.5.           By Source

11.3.2.2.6.           By Distribution Channel

11.3.3.  Colombia Generic Drugs Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Type

11.3.3.2.2.           By Application

11.3.3.2.3.           By Drug Delivery

11.3.3.2.4.           By Form

11.3.3.2.5.           By Source

11.3.3.2.6.           By Distribution Channel

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              Competition Outlook

14.2.              Company Profiles

14.2.1.  Teva Pharmaceutical Industries Ltd.

14.2.2.  Mylan NV

14.2.3.  Sandoz International GmbH (Novartis AG)

14.2.4.  Lupin Limited

14.2.5.  Pfizer Inc.

14.2.6.  Sun Pharmaceutical Industries Limited

14.2.7.  Endo Pharmaceuticals Inc.

14.2.8.  Aurobindo Pharma Limited

14.2.9.  Dr Reddy’s Laboratories Ltd.

14.2.10. Fresenius Kabi AG

14.2.11. Aspen Pharmacare Holdings Limited

14.2.12. Sanofi SA

14.2.13. Cipla Ltd.

14.2.14. Novo Nordisk A/S

14.2.15. Abbott Laboratories Inc.

15.  Strategic Recommendations

16.  About Us and Disclaimer

  • Figure 1: Global Generic Drugs Market Size, By Value (USD Billion), 2016-2026F

    Figure 2: Global Generic Drugs Market Share, By Type, 2016-2026F

    Figure 3: Global Generic Drugs Market Share, By Application, 2016-2026F

    Figure 4: Global Generic Drugs Market Share, By Drug Delivery, 2016-2026F

    Figure 5: Global Generic Drugs Market Share, By Form, 2016-2026F

    Figure 6: Global Generic Drugs Market Share, By Source, 2016-2026F

    Figure 7: Global Generic Drugs Market Share, By Distribution Channel, 2016-2026F

    Figure 8: Global Generic Drugs Market Share, By Company, 2016-2026F

    Figure 9: Global Generic Drugs Market Share, By Region, 2016-2026F

    Figure 10: Global Generic Drugs Product Market Map, By Region, By Value, 2016-2026F

    Figure 11: North America Generic Drugs Market Size, By Value (USD Billion), 2016-2026F

    Figure 12: North America Generic Drugs Market Share, By Type, 2016-2026F

    Figure 13: North America Generic Drugs Market Share, By Application, 2016-2026F

    Figure 14: North America Generic Drugs Market Share, By Drug Delivery, 2016-2026F

    Figure 15: North America Generic Drugs Market Share, By Form, 2016-2026F

    Figure 16: North America Generic Drugs Market Share, By Source, 2016-2026F

    Figure